<VariationArchive RecordType="classified" VariationID="2308" VariationName="NM_005609.4(PYGM):c.1725del (p.Lys575fs)" VariationType="Deletion" Accession="VCV000002308" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2015-04-08" MostRecentSubmission="2015-04-08">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="17347" VariationID="2308">
      <GeneList>
        <Gene Symbol="PYGM" FullName="glycogen phosphorylase, muscle associated" GeneID="5837" HGNC_ID="HGNC:9726" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="64746389" stop="64760715" display_start="64746389" display_stop="64760715" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="64513860" stop="64528186" display_start="64513860" display_stop="64528186" Strand="-" />
          </Location>
          <OMIM>608455</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_005609.4(PYGM):c.1725del (p.Lys575fs)</Name>
      <CanonicalSPDI>NC_000011.10:64751966:TTT:TT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="64751967" stop="64751967" display_start="64751967" display_stop="64751967" variantLength="1" positionVCF="64751966" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="64519439" stop="64519439" display_start="64519439" display_stop="64519439" variantLength="1" positionVCF="64519438" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>K487fs</ProteinChange>
      <ProteinChange>K575fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.64751969del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.64751969del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.64519441del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.64519441del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013018.1" sequenceAccession="NG_013018" sequenceVersion="1" change="g.13749del">
            <Expression>NG_013018.1:g.13749del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164716.1" sequenceAccession="NM_001164716" sequenceVersion="1" change="c.1461del">
            <Expression>NM_001164716.1:c.1461del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001158188.1" sequenceAccession="NP_001158188" sequenceVersion="1" change="p.Lys487fs">
            <Expression>NP_001158188.1:p.Lys487fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005609.4" sequenceAccession="NM_005609" sequenceVersion="4" change="c.1725del" MANESelect="true">
            <Expression>NM_005609.4:c.1725del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005600.1" sequenceAccession="NP_005600" sequenceVersion="1" change="p.Lys575fs">
            <Expression>NP_005600.1:p.Lys575fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA252208" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="608455.0011" DB="OMIM" />
        <XRef Type="rs" ID="786200874" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 9506549 Fig. 2B to determine the location of this allele on the current reference sequence. </Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005609.4(PYGM):c.1725del (p.Lys575fs) AND Glycogen storage disease, type V" Accession="RCV000002398" Version="4">
        <ClassifiedConditionList TraitSetID="585">
          <ClassifiedCondition DB="MedGen" ID="C0017924">Glycogen storage disease, type V</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1998-03-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1998-03-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-04-08" MostRecentSubmission="2015-04-08">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">9506549</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="585" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2239" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GSD 5</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">McArdle disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">McArdle type glycogen storage disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscle glycogen phosphorylase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myophosphorylase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease, type V</ElementValue>
                <XRef ID="Glycogen+Storage+Disease+Type+5/3125" DB="Genetic Alliance" />
                <XRef ID="55912009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease type 5</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GSD5</ElementValue>
                <XRef Type="MIM" ID="232600" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GSD V</ElementValue>
                <XRef Type="MIM" ID="232600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Glycogen storage disease type V (GSDV, McArdle disease) is a metabolic myopathy characterized by exercise intolerance manifested by rapid fatigue, myalgia, and cramps in exercising muscles. Symptoms are usually precipitated by isometric exercise or sustained aerobic exercise. Most individuals improve their exercise tolerance by exploiting the "second-wind" phenomenon with relief of myalgia and fatigue after a few minutes of rest. Age of onset is frequently in the first decade of life but can vary; however, diagnosis is typically delayed as myalgia and fatigability are dismissed/overlooked. Fixed muscle weakness occurs in approximately 25% of affected individuals, is more likely to involve proximal muscles, and is more common in individuals of advanced age. Approximately 50% of affected individuals have recurrent episodes of myoglobinuria that can – on occasion – eventually result in acute renal failure.</Attribute>
                <XRef ID="NBK1344" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6528" />
                <XRef ID="6528" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301518</ID>
                <ID Source="BookShelf">NBK1344</ID>
              </Citation>
              <XRef ID="368" DB="Orphanet" />
              <XRef ID="C0017924" DB="MedGen" />
              <XRef ID="MONDO:0009293" DB="MONDO" />
              <XRef Type="MIM" ID="232600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="22556" SubmissionDate="2015-04-02" DateLastUpdated="2015-04-08" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="608455.0011_MCARDLE DISEASE" title="PYGM, 1-BP DEL, A, CODON 753_MCARDLE DISEASE" />
        <ClinVarAccession Accession="SCV000022556" DateUpdated="2015-04-08" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1998-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">For discussion of the 1-bp deletion (A) n lys753 of the PYGM gene that was found in compound heterozygous state in a patient with myophosphorylase deficiency (GSD5; 232600) by Vorgerd et al. (1998), see 608455.0010.</Attribute>
              <Citation>
                <ID Source="PubMed">9506549</ID>
              </Citation>
              <XRef DB="OMIM" ID="232600" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PYGM" />
          </GeneList>
          <Name>PYGM, 1-BP DEL, A, CODON 753</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, A, CODON 753</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608455.0011" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MCARDLE DISEASE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="22556" TraitType="Disease" MappingType="Name" MappingValue="MCARDLE DISEASE" MappingRef="Preferred">
        <MedGen CUI="C0017924" Name="Glycogen storage disease, type V" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

